Ad
related to: basal cell carcinoma description dermatology procedure- aBCC Treatment Option
Visit The Patient Website Today To
Learn About This Treatment Option.
- Learn About Treatment
Discover Why This aBCC Treatment
Option May Be Right For You.
- How This Treatment Works
Explore Important Treatment Info
On The Official Patient Website.
- Patient Support Program
Sign Up For A Patient Support
Program For This aBCC Treatment.
- aBCC Treatment Option
Search results
Results from the WOW.Com Content Network
Dermatology [ edit on Wikidata ] Electrodesiccation and curettage ( EDC , ED & C , or ED+C ) is a medical procedure commonly performed by dermatologists , surgeons and general practitioners for the treatment of basal cell cancers and squamous cell cancers of the skin. [ 1 ]
The cure rate with Mohs surgery cited by most studies is between 97% and 99.8% for primary basal-cell carcinoma, the most common type of skin cancer. [2]: 13 Mohs procedure is also used for squamous cell carcinoma, but with a lower cure rate. Recurrent basal-cell cancer has a lower cure rate with Mohs surgery, more in the range of 94%.
Basal-cell carcinoma (BCC), also known as basal-cell cancer, basalioma [7] or rodent ulcer, [8] is the most common type of skin cancer. [2] It often appears as a painless raised area of skin, which may be shiny with small blood vessels running over it . [ 1 ]
Basal cell carcinoma is the most common form of skin cancer, affecting nearly 1 in 5 Americans, says Anne Sexton, physician assistant at Advanced Dermatology and Cosmetic Surgery in Fort Mill, S.C ...
Most small, low-risk and superficial skin cancers, such as basal cell carcinoma and squamous cell carcinoma, could be treated by curettage and electrosurgery. [6] A clinical margin which includes areas around the lesion site is marked out, and local anesthesia or numbing medicine is applied.
Of nonmelanoma skin cancers, about 80% are basal-cell cancers and 20% squamous-cell skin cancers. [14] Basal-cell and squamous-cell skin cancers rarely result in death. [6] In the United States, they were the cause of less than 0.1% of all cancer deaths. [1] Globally in 2012, melanoma occurred in 232,000 people and resulted in 55,000 deaths. [6]
HDR brachytherapy for nonmelanomatous skin cancer, such as basal cell carcinoma and squamous cell carcinoma, provides an alternative treatment option to surgery. This is especially relevant for cancers on the nose, ears, eyelids or lips, where surgery may cause disfigurement or require extensive reconstruction. [1]:
Ideally, the razor will shave only a small fragment of protruding tumor and leave the skin relatively flat after the procedure. Hemostasis is obtained using light electrocautery, Monsel's solution, or aluminum chloride. This is the ideal method of diagnosis for basal cell cancer.
Ad
related to: basal cell carcinoma description dermatology procedure